Who Paid My Doc
Alprolix
Biological Hematology
NDC 71104-911-01
General payments
$520,989
Research payments
$63,418
Through program year 2025, $520,989 in general payments and $63,418 in research payments were reported against Alprolix (Hematology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $10,344 | 276 |
| 2024 | General | $105,525 | 352 |
| 2024 | Research | $1,250 | 1 |
| 2023 | General | $54,959 | 181 |
| 2022 | General | $132,129 | 163 |
| 2021 | General | $69,677 | 86 |
| 2021 | Research | $750 | 2 |
| 2020 | General | $148,355 | 103 |
| 2020 | Research | $60,684 | 35 |
| 2019 | Research | $734 | 3 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 21 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 31 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,161 general · 41 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.